New anticoagulant drugs: Monitoring and perioperative strategies

Acta Anaesthesiologica Belgica

Volumn 57, Issue 4, 2006, Pages 409-418

  Ickx, Brigitte E ^a  

^a ERASME HOSPITAL   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 [(1 ACETIMIDOYL 3 PYRROLIDINYL)OXY]PHENYL] 3 (7 AMIDINO 2 NAPHTHYL)PROPIONIC ACID; 3 [7 [2 (3,4 DIFLUOROPHENYL)CYCLOPROPYLAMINO] 5 PROPYLTHIO 1,2,3 TRIAZOLO[4,5 D]PYRIMIDIN 3 YL] 5 HYDROXYMETHOXY 1,2 CYCLOPENTANEDIOL; ABCIXIMAB; ACETYLSALICYLIC ACID; ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ARGATROBAN; CANGRELOR; CLOPIDOGREL; DABIGATRAN ETEXILATE; DESULFATOHIRUDIN; DROTRECOGIN; ENOXAPARIN; EPTIFIBATIDE; FONDAPARINUX; HEPARIN; HIRULOG; IDRAPARINUX; LEPIRUDIN; LOW MOLECULAR WEIGHT HEPARIN; MELAGATRAN; PRASUGREL; RAZAXABAN; RECOMBINANT TISSUE FACTOR PATHWAY INHIBITOR; RIVAROXABAN; TICLOPIDINE; TIROFIBAN; UNINDEXED DRUG; WARFARIN; XIMELAGATRAN;

ANTICOAGULANT THERAPY; ARTERY THROMBOSIS; BLEEDING; CLINICAL TRIAL; CONFERENCE PAPER; DEEP VEIN THROMBOSIS; DRUG BIOAVAILABILITY; DRUG EFFICACY; DRUG HALF LIFE; DRUG MECHANISM; DRUG SAFETY; DRUG WITHDRAWAL; HEART INFARCTION; HUMAN; LOADING DRUG DOSE; MEDICAL INSTRUMENTATION; PERIOPERATIVE PERIOD; THROMBOCYTE FUNCTION; THROMBOCYTE TRANSFUSION; THROMBOCYTOPENIA; THROMBOELASTOGRAPHY; THROMBOGENESIS; VENOUS THROMBOEMBOLISM;

ANTICOAGULANTS; BLOOD COAGULATION; HUMANS; MONITORING, PHYSIOLOGIC; PERIOPERATIVE CARE; PLATELET AGGREGATION INHIBITORS; THROMBOSIS;

EID: 33846168709     PISSN: 00015164     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (43)

1. Agarwal S., Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry, ANESTHESIOLOGY, 105 (4), 676-83, 2006.
2. Albaladejo P., et le groupe de travail, Management of oral antiplatelet treatment for patients with coronary stents, ANN. FR. ANESTH. REANIM., 25 (7), 796-8, 2006.
3. Albaladejo P., French Society of Anesthesiology and Intensive Care, Perioperative management of antiplatelet agents in patients with coronary stents: recommendations of a French Task Force, BR. J. ANAESTH., 97 (4), 580-2, 2006.
4. Albaladejo P., Marret E., Piriou V., Samama C. M.; le Groupe d'Experts de la Societe Francaise d'Anesthesie et de Reanimation (SFAR), Early and late management of oral antiplatelet agents after coronary stenting, ANN. FR. ANESTH. REANIM., 25 (7), 686, 2006.
5. Bates S. M, New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin, BR. J. PHARMACOL., 144 (8), 1017-28, 2005.
6. Bates S. M., The status of new anticoagulants, BR. J. HAEMATOL., 134 (1), 3-19, 2006.
7. Bizzarri F., Perioperative use of tirofiban hydrochloride (Aggrastat) does not increase surgical bleeding after emergency or urgent coronary artery bypass grafting, J. THORAC. CARDIOVASC. SURG., 122 (6), 1181-5, 2001.
8. Carroll R. C., Measurement of patients' bivalirudin plasma levels by a thrombelastograph ecarin clotting time assay: a comparison to a standard activated clotting time, ANESTH. ANALG., 102 (5), 1316-9, 2006.
9. Cattaneo M., ADP receptors: inhibitory strategies for antiplatelet therapy, DRUG NEWS PERSPECT., 19 (5), 253, 2006.
10. Chu M. W., Does clopidogrel increase blood loss following coronary artery bypass surgery?, ANN. THORAC. SURG., 78 (5), 1536-41, 2004.
11. Craft R. M., Comparison of thromboelastograph and plateletworks whole blood assays to optical platelet aggregation for monitoring reversal of clopidogrel inhibition in elective surgery patients, J. LAB. CLIN. MED., 145, 309-15, 2005.
12. Depasse F., Assessment of three chromogenic and one clotting assays for the measurement of synthetic pentasaccharide fondaparinux (Arixtra) anti-Xa activity, J. THROMB. HAEMOST., 2 (2), 346-8, 2004.
13. Englberger L., Impact of clopidogrel in coronary artery bypass grafting, EUR. J. CARDIOTHORAC. SURG., 26(1), 96-101, 2004.
14. Fattorutto M., Does platelet function analyzer (PFA-100®) predict blood loss after cardiopulmonary bypass?, BR. J. ANAESTHESIA, 90, 692-3, 2003.
15. Forestier F., Platelet function point-of-care tests in post-bypass cardiac surgery: are they relevant?, BR. J. ANAESTH., 89 (5), 715-21, 2002.
16. Gansera B., Urgent or emergent coronary revascularization using bilateral internal thoracic artery after previous clopidogrel antiplatelet therapy, THORAC. CARDIOVASC. SURG., 51 (4), 185-9, 2003.
17. Gogarten W., The influence of new antithrombotic drugs on regional anesthesia, CURR. OPIN. ANAESTHESIOL., 19 (5), 545-50, 2006.
18. Kongo R. H., The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting, J. AM. COLL. CARDIOL., 40, 231-7, 2002.
19. Huvers F., Treatment of postoperative bleeding after fondaparinux with rFVIIa and tranexamic acid, NETH. J. MED., 63 (5), 184-6, 2005.
20. Ickx B. E., Preoperative stop or continue? New antithrombotic and anticoagulants, ACTA ANAESTHESIOL. BELG., 52 (4), 385-93, 2001.
21. Kapetanakis E. I., Effect of clopidogrel premedication in off-pump cardiac surgery: are we forfeiting the benefits of reduced hemorrhagic sequelae, CIRCULATION, 113, 1667-74, 2006.
22. Kapetanakis E. I., Medlam D. A., Boyce S. W., Haile E., Hill P.C., Dullum M. K., Bafi A. S., Petro K. R., Corso P. J., Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache?, EUR. HEART J., 26 (6), 576-83, 2005.
23. Karabulut H., Clopidogrel does not increase bleeding and allogenic blood transfusion in coronary artery surgery, EUROP. J. CARDIO-THORAC. SURG., 25, 419-23, 2004.
24. Katori N., A novel method to assess platelet inhibition by eptifibatide with TEG, ANESTH. ANALG., 6, 1784-9, 2004.
25. Kundu S. K., Description of an in vitro platelet function analyzer: PFA-100, SEMIN. THROMB. HEMOST., 21 (Suppl 2), S106-12, 1995.
26. Lasne D., From normal to pathological hemostasis, CAN. J. ANAESTH., 53 (6 Suppl.), S2-11, 2006.
27. Leong J. Y., Clopidogrel and bleeding after coronary artery bypass graft surgery, ANN. THORAC. SURG., 80 (3), 928-33, 2005.
28. Liesenfeld K. H., Effects of the direct thrombin inhibitor dabigatran on ex vivo coagulation time in orthopaedic surgery patients: a population model analysis, BR. J. CLIN. PHARMACOL., 62 (5), 527-37, 2006.
29. Mallet S. V., Thromboelastography, BR. J. ANAESTH., 69, 307-13, 1992.
30. Mangano D. T., Multicenter Study of Perioperative Ischemia Research Group; Ischemia Research and Education Foundation. The risk associated with aprotinin in cardiac surgery, N. ENGL. J. MED., 26, 354 (4), 353-65, 2006.
31. Pothula S., The effect of preoperative antiplatelet/anticoagulant prophylaxis on postoperative blood loss in cardiac surgery, ANESTH. ANALG., 98 (1), 4-10, 2004.
32. Roberts H. R., A cell-based model of thrombin generation, SEMIN. THROMB. HEMOST., 32, Suppl. 1, 32-8, 2006.
33. Samama C. M., French Society of Anesthesiology and Intensive Care. Antiplatelet agents in the perioperative period: expert recommendations of the French Society of Anesthesiology and Intensive Care (SFAR) 2001 - summary statement, CAN. J. ANAESTH., 49 (6), S26-35, 2002.
34. Shanmugam G., Tirofiban and emergency coronary surgery, EUR. J. CARDIOTHORAC. SURG., 28 (4), 546-50, 2005.
35. Singer D. E., Antithrombotic therapy in atrial fibrillation: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, CHEST. 126 (3 Suppl.), S429-456, 2004.
36. Spahn D. R., Coronary stents and perioperative antiplatelet regimen: dilemma of bleeding and stent thrombosis, BR. J. ANAESTH., 96 (6), 675-7, 2006.
37. Turpie A. G., Fondaparinux vs enoxaparin for the prevention of venous thromboembolism in major orthopedic surgery: a meta-analysis of 4 randomized double-blind studies, ARCH. INTERN. MED., 9, 162 (16), 1833-40, 2002.
38. van der Linden J., Aprotinin decreases postoperative bleeding and number of transfusions in patients on clopidogrel undergoing coronary artery bypass graft surgery: a double-blind, placebo-controlled, randomized clinical trial, CIRCULATION, 30, 112 (9 Suppl), 1276-80, 2005.
39. Vandermeulen E., Anaesthesia and new antithrombotic drugs, CURR. OPIN. ANAESTHESIOL., 18 (3), 353-9, 2005.
40. Vincenzi M. N., Coronary artery stenting and non-cardiac surgery - a prospective outcome study, BR. J. ANAESTH., 96 (6), 686-93, 2006.
41. Weitz J. I., New anticoagulant drugs: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy, CHEST, 126 (3 Suppl.), 265S-286S, 2004.
42. Whaba A., Are in-vitro platelet function texts useful in predicting blood loss following open heart surgery?, THORAC. CARDIOVASC. SURG., 46 (4), 228-31, 1998.
43. Yende S., Effect of clopidogrel on bleeding after coronary artery bypass surgery, CRIT. CARE MED., 29(12), 2271-5, 2001.